[1. RUIGOMEZ A, RODRIGUEZ LA, WALLANDER MA, JOHANSSON S, JONES R. Chest pain in general practice: incidence, comorbidity and mortality. Family practice 2006; 23: 167-174.10.1093/fampra/cmi12416461444]Search in Google Scholar
[2. APPEL GB. Thrombotic microangiopathies: Similar presentations, different therapies. Cleveland Clinic journal of medicine 2017; 84: 114-130.10.3949/ccjm.84gr.1700128198690]Search in Google Scholar
[3. GOVIND BABU K, BHAT GR. Cancer-associated thrombotic microangiopathy. Ecancermedicalscience 2016; 10: 649. DOI: 10.3332/ecancer.2016.649.10.3332/ecancer.2016.649492997727433282]Search in Google Scholar
[4. GEORGE JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116: 4060-4069.10.1182/blood-2010-07-27144520686117]Search in Google Scholar
[5. VESELY SK, GEORGE JN, LAMMLE B, STUDT JD, ALBERIO L, EL- HARAKE MA, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura- hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60-68.10.1182/blood-2003-01-019312637323]Search in Google Scholar
[6. GADDAM S, PABLANI L, CHAINANI V, KAVUDA RR, NAGRANI T, ABOU RJAILI G, et al. Complete recovery of ischemic cardiomyopathy from thrombotic thrombocytopenic purpura. Clinical Medicine Insights Cardiology 2011; 5: 29-33.10.4137/CMC.S6130307220921487455]Search in Google Scholar
[7. HAWKINS BM, ABU-FADEL M, VESELY SK, GEORGE JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 2008; 48: 382-392.]Search in Google Scholar
[8. BENHAMOU Y, BOELLE PY, BAUDIN B, EDERHY S, GRAS J, GALICIER L, et al. Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French thrombotic microangiopathies Reference Center. Journal of thrombosis and haemostasis : JTH 2015; 13: 293-302.10.1111/jth.1279025403270]Search in Google Scholar
[9. TASAKI T, YAMADA S, NABESHIMA A, NOGUCHI H, NAWATA A, HISAOKA M, et al. An autopsy case of myocardial infarction due to idiopathic thrombotic thrombocytopenic purpura. Diagnostic pathology 2015; 10: 52.10.1186/s13000-015-0285-1444684326022055]Search in Google Scholar
[10. VISAGIE GJ, LOUW VJ. Myocardial injury in HIV-associated thrombotic thrombocytopenic purpura (TTP). Transfusion medicine 2010; 20: 258-264.10.1111/j.1365-3148.2010.01006.x20409074]Search in Google Scholar
[11. PEREZ L, RAMAPPA P, GUZMAN JA. Myocardial injury in thrombotic thrombocytopenic purpura: a frequent, perplexing complication. International journal of cardiology 2008; 128: 257-260.10.1016/j.ijcard.2007.04.18117692959]Search in Google Scholar
[12. BRAZELTON J, OSTER RA, MCCLESKEY B, FULLER J, ADAMSKI J, MARQUES MB. Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura. Journal of clinical apheresis 2017; 32: 311-318.10.1002/jca.2151027717013]Search in Google Scholar
[13. GEORGE JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1935.10.1056/NEJMcp05302416672704]Search in Google Scholar
[14. BLOMBERY P, SCULLY M. Management of thrombotic thrombocytopenic purpura: current perspectives. Journal of blood medicine 2014; 5: 15-23.10.2147/JBM.S46458]Search in Google Scholar